Global Radiation Toxicity Therapeutics Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Radiation Toxicity Therapeutics Market Insights, Forecast to 2034
Treatment of acute radiation syndrome is generally supportive care. This may include blood transfusions, antibiotics, colony-stimulating factors, or stem cell transplant. If radioactive material remains on the skin or in the stomach it should be removed.
Market Analysis and InsightsGlobal Radiation Toxicity Therapeutics Market
Global Radiation Toxicity Therapeutics market is expected to reach to US$ 3987 million in 2024, with a positive growth of %, compared with US$ 3762 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Radiation Toxicity Therapeutics industry is evaluated to reach US$ 5591.9 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
The radiation toxicity treatment market is driven by the increasing use of radiation therapy in cancer treatment and the growing number of nuclear accidents and incidents. Radiation therapy is a critical component in cancer treatment, but it can lead to radiation toxicity, causing various side effects in patients. As the number of cancer cases rises, the demand for radiation therapy is also increasing, consequently driving the need for effective radiation toxicity treatments. Additionally, nuclear accidents and incidents, such as nuclear power plant disasters and radiation exposure from accidents or terrorism, highlight the importance of developing treatments for radiation toxicity. However, the challenge lies in developing treatments that effectively mitigate the harmful effects of radiation while minimizing side effects. Additionally, regulatory approvals and safety concerns are significant challenges in bringing radiation toxicity treatments to the market. Collaborative research efforts and advancements in medical technology are vital in addressing these challenges and providing safer and more effective radiation toxicity treatments.
Report Covers
This report presents an overview of global Radiation Toxicity Therapeutics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Radiation Toxicity Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Amgen
Partner Therapeutics
Novartis
Viatris
Coherus BioSciences
Jubilant Life Sciences
Siegfried Holdings
Recipharm AB
Mission Pharmacal Company
Segment by Type
Ionizing Radiation
Non-ionizing Radiation
Hospital
Research & Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Radiation Toxicity Therapeutics introduction, etc. Radiation Toxicity Therapeutics Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Radiation Toxicity Therapeutics
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Radiation Toxicity Therapeutics Market
Global Radiation Toxicity Therapeutics market is expected to reach to US$ 3987 million in 2024, with a positive growth of %, compared with US$ 3762 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Radiation Toxicity Therapeutics industry is evaluated to reach US$ 5591.9 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
The radiation toxicity treatment market is driven by the increasing use of radiation therapy in cancer treatment and the growing number of nuclear accidents and incidents. Radiation therapy is a critical component in cancer treatment, but it can lead to radiation toxicity, causing various side effects in patients. As the number of cancer cases rises, the demand for radiation therapy is also increasing, consequently driving the need for effective radiation toxicity treatments. Additionally, nuclear accidents and incidents, such as nuclear power plant disasters and radiation exposure from accidents or terrorism, highlight the importance of developing treatments for radiation toxicity. However, the challenge lies in developing treatments that effectively mitigate the harmful effects of radiation while minimizing side effects. Additionally, regulatory approvals and safety concerns are significant challenges in bringing radiation toxicity treatments to the market. Collaborative research efforts and advancements in medical technology are vital in addressing these challenges and providing safer and more effective radiation toxicity treatments.
Report Covers
This report presents an overview of global Radiation Toxicity Therapeutics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Radiation Toxicity Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Amgen
Partner Therapeutics
Novartis
Viatris
Coherus BioSciences
Jubilant Life Sciences
Siegfried Holdings
Recipharm AB
Mission Pharmacal Company
Segment by Type
Ionizing Radiation
Non-ionizing Radiation
Segment by Application
Hospital
Research & Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Radiation Toxicity Therapeutics introduction, etc. Radiation Toxicity Therapeutics Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Radiation Toxicity Therapeutics
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports